Contrast-enhanced ultrasound with microflow imaging provides noninvasive analysis of the vascular structure and hemodynamics of liver nodules. This analysis, in turn, provides information about how advanced hepatocellular carcinoma is.
Contrast-enhanced ultrasound with microflow imaging provides noninvasive analysis of the vascular structure and hemodynamics of liver nodules. This analysis, in turn, provides information about how advanced hepatocellular carcinoma is.
Dr. Katsutoshi Sugimoto and colleagues in the gastroenterology and hepatology department at Tokyo Medical University, along with Toshiba and Hyogo College of Medicine in Hyogo, Japan, studied a total of 61 liver nodules with contrast-enhanced ultrasound using microflow imaging. They were able to see the blood vessels down to the fine branches.
Two independent readers classified each nodule according to its vascular framework as having a normal, cotton, vascular, or deadwood pattern. The researchers then compared these results with the histological diagnoses of the nodules.
Of the 61 total nodules, 20 were well-differentiated, 26 were moderately differentiated, and 15 were poorly differentiated hepatocellular carcinomas.
A poorly differentiated vascular structure in hepatocellular carcinoma correlates with advanced cancer, usually metastasized to distant sites.
The researchers published their findings in Hepatology Research, which made it available online May 27.
They found that normal and cotton ultrasound patterns were associated with well-differentiated hepatocellular carcinoma, while the vascular pattern was associated with moderately differentiated nodules, and the deadwood pattern was associated with poorly differentiated hepatocellular carcinomas.
Using these criteria, assessments by reader one showed an 85% sensitivity, 92.7% specificity, and 90% accuracy. Assessments by reader two showed an 85% sensitivity, 82.9% specificity, and 83.6% accuracy.
The researchers concluded that contrast-enhanced ultrasound with microflow imaging could be used to get an accurate view of the vascular structure of hepatocellular carcinoma.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Point-Of-Care Ultrasound Platform and AI Software for Neuraxial Procedures
July 17th 2025The dual FDA clearances for the Accuro 3S point-of-care ultrasound device and the SpineNav-AI machine learning-based software may enhance precision and safety with ultrasound-guided neuraxial procedures.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.